Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer

被引：8

作者：

Abbas, Ghulam ^{[1
]}

Danish, Adnan ^{[2
]}

Krasna, Mark J. ^{[3
]}

机构：

[1] Meridian Hlth, Minimally Invas Thorac Surg, 1 Riverview Plaza, Red Bank, NJ 07701 USA

[2] Meridian Hlth, Radiat Oncol, 1 Riverview Plaza, Red Bank, NJ 07701 USA

[3] Jersey Shore Univ, Meridian Canc Care, Med Ctr, Ackerman South, Room 553,1945 Route 33, Neptune, NJ 07753 USA

来源：

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2016年 / 25卷 / 03期

关键词：

Stereotactic body radiation therapy (SBRT); Radiofrequency ablation; Microwave ablation; Ablative therapies for lung cancer; Stereotactic ablative therapy (SABR); PERCUTANEOUS RADIOFREQUENCY ABLATION; MEDICALLY INOPERABLE PATIENTS; HIGH-RISK PATIENTS; PHASE-II TRIAL; STAGE-I; RADIATION-THERAPY; SUBLOBAR RESECTION; ANATOMIC SEGMENTECTOMY; MATCHED ANALYSIS; DOSE-ESCALATION;

D O I：

10.1016/j.soc.2016.02.008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The treatment paradigm for early stage lung cancer and oligometastatic disease to the lung is rapidly changing. Ablative therapies, especially stereotactic body radiation therapy, are challenging the surgical gold standard and have the potential to be the standard for operable patients with early stage lung cancer who are high risk due to co- morbidities. The most commonly used ablative modalities include stereotactic body radiation therapy, microwave ablation, and radiofrequency ablation.

引用

页码：553 / +

页数：15

共 50 条

[1] Stereotactic Ablative Body Radiotherapy for Lung Cancer
Franks, K. N.
Jain, P.
Snee, M. P.
[J]. CLINICAL ONCOLOGY, 2015, 27 (05) : 280 - 289
[2] Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy
Siva, S.
Senan, S.
Ball, D.
[J]. ANNALS OF ONCOLOGY, 2015, 26 (10) : 2196 - 2196
[3] PATIENT SPECIFIC QUALITY ASSURANCE FOR LUNG CANCER STEREOTACTIC ABLATIVE BODY RADIOTHERAPY
Hardcastle, Nicholas
Clements, Natalie
Siva, Shankar
Ball, David
Kron, Tomas
[J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1139 - S1140
[4] Outcomes after stereotactic ablative body radiotherapy for stage 1 lung cancer
Phillips, I.
Chandy, E.
Yusof, H.
Lodge, D.
Bishop, L.
Mahendran, P.
Halling-Brown, M.
Saxby, H.
Ezhil, V.
[J]. LUNG CANCER, 2019, 127 : S72 - S73
[5] A case for development of stereotactic ablative body radiotherapy (SABR) for lung cancer at Aberdeen
Stilwell, C.
Steven, E.
Sharma, R. N.
Bissett, D.
Shrimali, R. K.
[J]. LUNG CANCER, 2013, 79 : S58 - S59
[6] Implementation of Stereotactic Ablative Radiotherapy (Stereotactic Body Radiotherapy)
Kirkbride, P.
Hoskin, P. J.
[J]. CLINICAL ONCOLOGY, 2012, 24 (09) : 627 - 628
[7] Stereotactic ablative body radiotherapy in patients with prostate cancer
Loblaw, Andrew
Liu, Stanley
Cheung, Patrick
[J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 (03) : 330 - 340
[8] Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer
Desai, Neil B.
Laine, Aaron M.
Timmerman, Robert D.
[J]. BRITISH JOURNAL OF RADIOLOGY, 2017, 90 (1070):
[9] Immunomodulatory effect of stereotactic ablative radiotherapy in lung cancer
Domagala-Kulawik, Joanna
[J]. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (04): : 233 - 234
[10] STEREOTACTIC BODY ABLATIVE RADIOTHERAPY FOR STAGE I NON SMALL CELL LUNG CANCER
Beltramo, G.
Bergantin, A.
Martinotti, A.
Bonfanti, P.
Bianchi, L. C.
[J]. RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S570 - S571

← 1 2 3 4 5 →